The National Cancer Institute (NCI) Rectal-Anal Task Force has released consensus recommendations for the design of future clinical trials involving rectal cancer patients. These guidelines emphasize the importance of including patient-centric endpoints, determining the best use of radiation and neoadjuvant therapy, and focusing on specific rectal cancer subpopulations and unique trial design features.
Keep Reading
Add A Comment